Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects

Summary

The objective of this study is to evaluate and compare the bioavailability of mesalamine

Timeline

Start

2017-05-15

Primary completion

2017-06-23

Completion

2017-08-18

Drugs

Indications